Foszfodiészteráz-gátlók (Hungarian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Foszfodiészteráz-gátlók" in Hungarian language version.

refsWebsite

Global rank Hungarian rank

18nih.gov

4^th place

11^th place

16doi.org

2^nd place

8^th place

3archive.org

6^th place

14^th place

2elsevier.com

610^th place

1,534^th place

1atsjournals.org

low place

1jimmunol.org

low place

1wipo.int

1,462^nd place

4,141^st place

1web.archive.org

1^st place

archive.org

(1977) „Selective cyclic nucleotide phosphodiesterase inhibitors as potential therapeutic agents”. Annu. Rev. Pharmacol. Toxicol 17, 441–477. o. DOI:10.1146/annurev.pa.17.040177.002301. PMID 17360.
Essayan DM. (2001). „Cyclic nucleotide phosphodiesterases.”. The Journal of Allergy and Clinical Immunology 108 (5), 671–80. o. DOI:10.1067/mai.2001.119555. PMID 11692087.
(1988) „Caffeine and theophylline analogues: correlation of behavioral effects with activity as adenosine receptor antagonists and as phosphodiesterase inhibitors”. Life Sciences 43 (5), 387–98. o. DOI:10.1016/0024-3205(88)90517-6. PMID 2456442.

atsjournals.org

ajrccm.atsjournals.org

(1999. február 1.) „Pentoxifylline inhibits TNF-alpha production from human alveolar macrophages”. Am. J. Respir. Crit. Care Med. 159 (2), 508–11. o. DOI:10.1164/ajrccm.159.2.9804085. PMID 9927365.

doi.org

dx.doi.org

(1972) „Separation of multiple molecular forms of cyclic adenosine 3',5'-monophosphate phosphodiesterase in rat cerebellum by polyacrylamide gel electrophoresis”. Biochim. Biophys. Acta 284, 220–226. o. DOI:10.1016/0005-2744(72)90060-5. PMID 4342220.
(1977) „Selective cyclic nucleotide phosphodiesterase inhibitors as potential therapeutic agents”. Annu. Rev. Pharmacol. Toxicol 17, 441–477. o. DOI:10.1146/annurev.pa.17.040177.002301. PMID 17360.
Essayan DM. (2001). „Cyclic nucleotide phosphodiesterases.”. The Journal of Allergy and Clinical Immunology 108 (5), 671–80. o. DOI:10.1067/mai.2001.119555. PMID 11692087.
(2008) „Insights into the Regulation of TNF-α Production in Human Mononuclear Cells: The Effects of Non-Specific Phosphodiesterase Inhibition”. Clinics (Sao Paulo). 63 (3), 321–8. o. DOI:10.1590/S1807-59322008000300006. PMID 18568240. PMC 2664230.
(1999. február 1.) „Pentoxifylline inhibits TNF-alpha production from human alveolar macrophages”. Am. J. Respir. Crit. Care Med. 159 (2), 508–11. o. DOI:10.1164/ajrccm.159.2.9804085. PMID 9927365.
(2005) „Leukotrienes: underappreciated mediators of innate immune responses”. Journal of Immunology 174 (2), 589–94. o. DOI:10.4049/jimmunol.174.2.589. PMID 15634873.
(1929. július 1.) „THE SYNTHESIS OF SOME ALKYLXANTHINES”. Journal of the American Chemical Society 51 (7), 2245–2251. o. DOI:10.1021/ja01382a042.
(1986. július 1.) „Analogues of caffeine and theophylline: effect of structural alterations on affinity at adenosine receptors”. Journal of Medicinal Chemistry 29 (7), 1305–8. o. DOI:10.1021/jm00157a035. PMID 3806581.
(1988) „Caffeine and theophylline analogues: correlation of behavioral effects with activity as adenosine receptor antagonists and as phosphodiesterase inhibitors”. Life Sciences 43 (5), 387–98. o. DOI:10.1016/0024-3205(88)90517-6. PMID 2456442.
(1989. június 1.) „Effects of 8-phenyl and 8-cycloalkyl substituents on the activity of mono-, di-, and trisubstituted alkylxanthines with substitution at the 1-, 3-, and 7-positions”. Journal of Medicinal Chemistry 32 (6), 1231–7. o. DOI:10.1021/jm00126a014. PMID 2724296.
(1991) „Caffeine analogs: structure-activity relationships at adenosine receptors”. Pharmacology 42 (6), 309–21. o. DOI:10.1159/000138813. PMID 1658821.
(1993. február 1.) „Adenosine receptor-blocking xanthines as inhibitors of phosphodiesterase isozymes”. Biochemical Pharmacology 45 (4), 847–51. o. DOI:10.1016/0006-2952(93)90168-V. PMID 7680859.
Daly JW (2000. július 1.). „Alkylxanthines as research tools”. Journal of the Autonomic Nervous System 81 (1–3), 44–52. o. DOI:10.1016/S0165-1838(00)00110-7. PMID 10869699.
Daly JW (2007. augusztus 1.). „Caffeine analogs: biomedical impact”. Cellular and Molecular Life Sciences : CMLS 64 (16), 2153–69. o. DOI:10.1007/s00018-007-7051-9. PMID 17514358.
(2008. május 1.) „Search for new antagonist ligands for adenosine receptors from QSAR point of view. How close are we?”. Medicinal Research Reviews 28 (3), 329–71. o. DOI:10.1002/med.20108. PMID 17668454.
(2008. január 1.) „Adenosine receptor antagonists: translating medicinal chemistry and pharmacology into clinical utility”. Chemical Reviews 108 (1), 238–63. o. DOI:10.1021/cr0682195. PMID 18181659.

elsevier.com

linkinghub.elsevier.com

(1993. február 1.) „Adenosine receptor-blocking xanthines as inhibitors of phosphodiesterase isozymes”. Biochemical Pharmacology 45 (4), 847–51. o. DOI:10.1016/0006-2952(93)90168-V. PMID 7680859.
Daly JW (2000. július 1.). „Alkylxanthines as research tools”. Journal of the Autonomic Nervous System 81 (1–3), 44–52. o. DOI:10.1016/S0165-1838(00)00110-7. PMID 10869699.

jimmunol.org

(2005) „Leukotrienes: underappreciated mediators of innate immune responses”. Journal of Immunology 174 (2), 589–94. o. DOI:10.4049/jimmunol.174.2.589. PMID 15634873.

nih.gov

pubmed.ncbi.nlm.nih.gov

(1972) „Separation of multiple molecular forms of cyclic adenosine 3',5'-monophosphate phosphodiesterase in rat cerebellum by polyacrylamide gel electrophoresis”. Biochim. Biophys. Acta 284, 220–226. o. DOI:10.1016/0005-2744(72)90060-5. PMID 4342220.
(1977) „Selective cyclic nucleotide phosphodiesterase inhibitors as potential therapeutic agents”. Annu. Rev. Pharmacol. Toxicol 17, 441–477. o. DOI:10.1146/annurev.pa.17.040177.002301. PMID 17360.
Essayan DM. (2001). „Cyclic nucleotide phosphodiesterases.”. The Journal of Allergy and Clinical Immunology 108 (5), 671–80. o. DOI:10.1067/mai.2001.119555. PMID 11692087.
(2008) „Insights into the Regulation of TNF-α Production in Human Mononuclear Cells: The Effects of Non-Specific Phosphodiesterase Inhibition”. Clinics (Sao Paulo). 63 (3), 321–8. o. DOI:10.1590/S1807-59322008000300006. PMID 18568240. PMC 2664230.
(1999. február 1.) „Pentoxifylline inhibits TNF-alpha production from human alveolar macrophages”. Am. J. Respir. Crit. Care Med. 159 (2), 508–11. o. DOI:10.1164/ajrccm.159.2.9804085. PMID 9927365.
(2005) „Leukotrienes: underappreciated mediators of innate immune responses”. Journal of Immunology 174 (2), 589–94. o. DOI:10.4049/jimmunol.174.2.589. PMID 15634873.
(1987) „Adenosine receptors: development of selective agonists and antagonists”. Prog Clin Biol Res. 230 (1), 41–63. o. PMID 3588607.
(1986. július 1.) „Analogues of caffeine and theophylline: effect of structural alterations on affinity at adenosine receptors”. Journal of Medicinal Chemistry 29 (7), 1305–8. o. DOI:10.1021/jm00157a035. PMID 3806581.
(1987) „Adenosine receptors: development of selective agonists and antagonists”. Progress in Clinical and Biological Research 230, 41–63. o. PMID 3588607.
(1988) „Caffeine and theophylline analogues: correlation of behavioral effects with activity as adenosine receptor antagonists and as phosphodiesterase inhibitors”. Life Sciences 43 (5), 387–98. o. DOI:10.1016/0024-3205(88)90517-6. PMID 2456442.
(1989. június 1.) „Effects of 8-phenyl and 8-cycloalkyl substituents on the activity of mono-, di-, and trisubstituted alkylxanthines with substitution at the 1-, 3-, and 7-positions”. Journal of Medicinal Chemistry 32 (6), 1231–7. o. DOI:10.1021/jm00126a014. PMID 2724296.
(1991) „Caffeine analogs: structure-activity relationships at adenosine receptors”. Pharmacology 42 (6), 309–21. o. DOI:10.1159/000138813. PMID 1658821.
(1993. február 1.) „Adenosine receptor-blocking xanthines as inhibitors of phosphodiesterase isozymes”. Biochemical Pharmacology 45 (4), 847–51. o. DOI:10.1016/0006-2952(93)90168-V. PMID 7680859.
Daly JW (2000. július 1.). „Alkylxanthines as research tools”. Journal of the Autonomic Nervous System 81 (1–3), 44–52. o. DOI:10.1016/S0165-1838(00)00110-7. PMID 10869699.
Daly JW (2007. augusztus 1.). „Caffeine analogs: biomedical impact”. Cellular and Molecular Life Sciences : CMLS 64 (16), 2153–69. o. DOI:10.1007/s00018-007-7051-9. PMID 17514358.
(2008. május 1.) „Search for new antagonist ligands for adenosine receptors from QSAR point of view. How close are we?”. Medicinal Research Reviews 28 (3), 329–71. o. DOI:10.1002/med.20108. PMID 17668454.
(2008. január 1.) „Adenosine receptor antagonists: translating medicinal chemistry and pharmacology into clinical utility”. Chemical Reviews 108 (1), 238–63. o. DOI:10.1021/cr0682195. PMID 18181659.

ncbi.nlm.nih.gov

(2008) „Insights into the Regulation of TNF-α Production in Human Mononuclear Cells: The Effects of Non-Specific Phosphodiesterase Inhibition”. Clinics (Sao Paulo). 63 (3), 321–8. o. DOI:10.1590/S1807-59322008000300006. PMID 18568240. PMC 2664230.

web.archive.org

WO patent 1985002540 Archiválva 2011. augusztus 5-i dátummal a Wayback Machine-ben, Sunshine A, Laska EM, Siegel CE, "ANALGESIC AND ANTI-INFLAMMATORY COMPOSITIONS COMPRISING XANTHINES AND METHODS OF USING SAME", granted 1989-03-22 , assigned to RICHARDSON-VICKS, INC.

wipo.int

WO patent 1985002540 Archiválva 2011. augusztus 5-i dátummal a Wayback Machine-ben, Sunshine A, Laska EM, Siegel CE, "ANALGESIC AND ANTI-INFLAMMATORY COMPOSITIONS COMPRISING XANTHINES AND METHODS OF USING SAME", granted 1989-03-22 , assigned to RICHARDSON-VICKS, INC.